BUSINESS - Pharma Japan -

Thursday, October.18.2018

Remember Me

Home＞BUSINESS

Takeda, Whiz Partners to Set Up Joint Investment Fund to Spur Drug Ecosystem
August 6.2018
Amgen Astellas Seeks OK for Repatha Monotherapy Use in Statin-Intolerant Patients
August 6.2018
Rituxan Filed for Add’l Indication of Chronic Lymphocytic Leukemia
August 6.2018
Opdivo Defended Crown with Ono’s Asia Sales Added, but Keytruda Triumph Would Come Soon
August 6.2018
AstraZeneca’s Japan Crestor Sales Dive 71%
August 3.2018
Ninlaro Production Site Opens in Russia: Takeda
August 3.2018
Thrombocytopenia Drug Mulpleta Earns FDA Approval: Shionogi
August 3.2018
Recomodulin Fails to Hit Primary Goal in PIII for Severe Sepsis with Coagulopathy: Asahi Kasei
August 3.2018
Eisai Neurology Chief Shows Eagerness on Alzheimer’s Combination Trials
August 2.2018
AstraZeneca’s AI Translation System Could Bring Huge Impact If Materialized: Japan R&D Chief
August 2.2018

＜ Prev 13 14 15 16 17 18 19 20 21 22 Next ＞

There’s Room for Growth in Biosimilar Space, but Who Will Grab It?

G1/G2 Rule：
G1/G2ルール

Finding Captains in Your Organization

JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near(Oct.17)

MHLW Lifts Contraindications for Combined Statin-Fibrate Use in Renal-Impaired Patients(Oct.17)

Eisai Seals Latin America Pact for Belviq(Oct.17)

Teva Takeda Launches Voluntary Recall for Taxotere Generics(Oct.17)

ADR Victim Relief Claims Fall below 1,500 in FY2017: MHLW(Oct.17)

1.: MHLW Panelists Frown on Use of Economic ...
2.: Hep C Market Shrinking towards Disease E...
3.: Chugai Sues Daiichi Sankyo, Pfizer over ...
4.: MOF Reiterates Drug Cost Optimization, b...
5.: Nobel Laurate Honjo Prods Minister on In...